Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202403531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yunlong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Gu…. Hauptthemen laut MEDLINE: Oxaliplatin, Colorectal Neoplasms, Extracellular Vesicles, Proto-Oncogene Proteins c-mdm2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Technology Planning Project of Ganzhou, Science and Technology Plan of Guangzhou, Natural Science Foundation of Guangdong.
Abstract (Originalsprache)
Oxaliplatin (OXA) is the first‐line drug for the treatment of colorectal cancer (CRC), and susceptibility to drug resistance affects patient prognosis. However, the exact underlying mechanisms remain unclear. Platinum‐acquired resistance in CRC is a continuous transition process; though, current research has mainly focused on the end state of drug resistance, and the early events of drug resistance have been ignored. In this study, single‐cell transcriptome sequencing is combined with a dynamic network biomarker (DNB), and found that the functional inhibition of the mitochondrial electron transport chain complex I occur early in the development of attained resistance to OXA in CRC cells, as evidenced by a decrease in the levels of subunit proteins, primarily NDUFB8. Specifically, the mouse double minute 2 homologue (MDM2) mediates the ubiquitination and degradation of NDUFB8, reducing intracellular reactive oxygen species (ROS) generation under chemotherapeutic stress, consequently contributing to drug resistance. Based on this, the study constructs engineered extracellular vesicles carrying siMDM2 by electroporation and validates the application of EV‐siMDM2 to improve the efficacy of OXA‐based chemotherapy by inhibiting the MDM2/NDUFB8/ROS signaling axis in patient‐derived xenograft (PDX) and hepatic and pulmonary metastasis mouse models, thus providing new ideas and an experimental basis for the platinum‐resistant treatment of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510000, China.
- Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510000, China.
- Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510000, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510000, China.
- Department of General Surgery, Guangdong Provincial People's Hospital Ganzhou Hospital (Ganzhou Municipal Hospital), Ganzhou, 341000, China.
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, China.
ORCID-Profile: Xueqing Yao
Förderung
- Science and Technology Planning Project of Ganzhou
- Science and Technology Plan of Guangzhou
- Natural Science Foundation of Guangdong
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Li, Y., Liu, Z., Wang, P., Gu, X., Ling, F., Zhong, J., Yin, D., Liu, R., Yao, X., & Huang, C. (2025). Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403531
Vancouver
Li Y, Liu Z, Wang P, Gu X, Ling F, Zhong J, et al. Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403531
BibTeX
@article{Li2025,
author = {Li, Yunlong and Liu, Zhiyuan and Wang, Ping and Gu, Xuerong and Ling, Fei and Zhong, Jiayuan and Yin, Dong and Liu, Rui and Yao, Xueqing and Huang, Chengzhi},
title = {Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202403531}
}
EUVIMED